![](/img/cover-not-exists.png)
PMC17 SHOULD INDIRECT COSTS OF ILLNESS BE INCLUDED IN PHARMACOECONOMIC ANALYSIS: SURVEY AMONG POLISH DECISION MAKERS AND EXPERTS
W Wrona, D Golicki, M Jakubczyk, M Niewada, M Czech, T Macioch, T HermanowskiVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74919-6
File:
PDF, 98 KB
english, 2009